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Pneumonia
Biomarkers
Emergency physicians often face the routine challenge of
predicting short- to mid-term adverse outcomes for
patients with community acquired pneumonia (CAP) with
low risk of complication. As biomarkers have signifi-
cantly improved practices in emergency medicine, it was
suggested that they could help management of CAP.
Indeed, procalcitonin (PCT) measurement allows early
discontinuation of antimicrobial agents in patients with
CAP and may predict severity [1]. In this context,
Claessens et al. [2] tested the usefulness of several bio-
markers, including procalcitonin, C-reactive protein
(CRP) and mid-regional pro-atrial peptide, in a large
prospective multicentre study that included 419 patients
with mild CAP. The initial measurement of mid-regional
pro-atrial peptide accurately identified low-risk CAP
patients requiring hospitalization following initial emer-
gency department (ED) visit, with better operating
characteristics than CRP and PCT.
Early onset pneumonia is frequently reported after
cardiac arrest, despite the fact that therapeutic hypother-
mia and post-resuscitation disease manifestations make it
difficult to diagnose. In order to assess the ability of
serum PCT measurements to help diagnose pneumonia in
this setting, Mongardon et al. [3] studied 132 consecutive
patients admitted to intensive care unit (ICU) after a
successfully resuscitated cardiac arrest, of whom 86 had
developed pneumonia. Although PCT was significantly
higher in patients with pneumonia at day 1, negative
predictive values were 39% at admission, 42% at day 1
and 52% at day 2, whereas positive predictive values were
72, 68 and 70%, respectively. These results confirm that
the diagnostic value of PCT is poor after cardiac arrest,
probably because the post-resuscitation disease itself
could lead to a major increase in PCT levels.
Simple criteria allowing pneumonia to be confirmed or
ruled out at an early stage of management of ICU patients
requiring mechanical ventilation would be clinically
useful. To evaluate the respective and combined useful-
ness of the Clinical Pulmonary Infection Score (CPIS),
bronchoalveolar lavage (BAL) gram staining, endotra-
cheal aspirate surveillance culture, and BAL and serum
procalcitonin, Jung et al. studied 57 ICU patients clini-
cally suspected of having developed ventilator-associated
pneumonia (VAP) [4]. No differences were found in
alveolar or serum procalcitonin between VAP and non-
VAP patients, confirming that procalcitonin is not an
accurate marker of VAP. In contrast, microbiological
resources available at the time of VAP suspicion (BAL
gram staining, last available endotracheal aspirate) com-
bined or not with CPIS were helpful in distinguishing
VAP diagnosed by BAL from patients with a negative
BAL. Including procalcitonin in the CPIS score did not
increase its accuracy (55%) for the diagnosis of VAP.
Adjuvant therapy in patients with pneumonia
Macrolides may have beneficial effects in severe CAP
because of their immunomodulatory effects rather than
their antimicrobial properties. Several recent studies
suggest that adding macrolides to beta-lactams results in
better mortality when compared with beta-lactam single-
drug therapy in hospitalized patients with CAP [5] or
when compared with the combination of beta-lactam plus
quinolone in patients with CAP admitted to the ICU (HR
0.48, 95% CI 0.23–0.97, p = 0.04). When more severe
patients presenting severe sepsis and septic shock were
analysed in this latter study, similar results were obtained
(HR 0.44, 95% CI 0.20–0.95, p = 0.03) [6].
The administration of corticosteroids in CAP is a
controversial issue. Snijders et al. [7] performed a ran-
domized double-blinded clinical trial comparing the
administration of corticosteroids plus antibiotics with
antibiotics alone. There were no differences in outcome.
However, the inclusion of patients with very severe CAP
(which should be the target population) was low. Not
surprisingly, coadjuvant therapy with corticosteroids has
also been proposed for treating patients with severe H1N1
influenza A-associated respiratory failure, with two large
studies reporting the use of corticosteroids in 51–69% of
patients [8, 9]. In a small series of 13 acute respiratory
distress syndrome (ARDS) patients, with and without
confirmed H1N1 influenza, prolonged low-to-moderate
dose corticosteroid treatment in addition to oseltamivir
was well tolerated and associated with significant
improvement in lung injury and multiple organ dysfunc-
tion scores and a low hospital mortality [10]. However,
whether or not corticosteroids are really beneficial in this
setting remains highly debated [11, 12] and additional
studies exploring this issue are mandatory before firm
conclusions can be drawn.
Prevention of VAP
Selective digestive microbial decontamination (SDD) is
hypothesized to benefit patients in ICU by suppressing
Gram-negative potential pathogens from the colon without
affecting the anaerobic intestinal microbiota. To provide
more insight into this important issue, Benus et al. [13, 14]
used fluorescent in situ hybridization to analyse the faecal
microbiota from a subset of ICU patients who were enrolled
in a large multicentre trial to study the outcome of SDD and
selective oral decontamination (SOD) in comparison with
standard care (SC). Results clearly demonstrated that the
composition of the intestinal microbiota was importantly
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affected by SDD, with a significant suppression of the
anaerobic F. prausnitzii group of bacteria during SDD. This
group of microbiota, which is one of the predominant
bacterial groups in healthy volunteers, representing
10–15% of the intestinal microbiota on average, plays an
important role in maintaining the colonization resistance,
normally protecting the human host from infections. F.
prausnitzii has also been found to promote the growth of
colonocytes through its production of butyrate, preventing
mucosal atrophy. Interestingly, Dutch investigators also
recently reported that SOD and SDD have marked effects
on the bacterial ecology of ICU patients, with rising ceft-
azidime resistance prevalence rates in the respiratory tract
during intervention and a considerable rebound effect of
ceftazidime resistance in the intestinal tract after discon-
tinuation of SDD [15].
Prevention of VAP requires a complex approach that
should include factors affecting healthcare workers’
(HCWs) behaviour. In a study designed to assess which
individual factors interplayed in a multifaceted program
focusing on VAP prevention, Bouadma et al. [16] deter-
mined that five cognitive factors were significantly
associated with knowledge at the end of the educational
program: perceived susceptibility, seriousness, knowl-
edge, benefits and self-efficacy. Behaviour changes were
especially pronounced for HCWs with the lowest baseline
cognitive profiles.
Polyurethane (PU)-cuffed tracheal tubes have been
shown to decrease leakage of oropharyngeal secretions
and thus could lower nosocomial pneumonia rates [17].
However, because of the thickness, lower resistance, and
resting volume of polyurethane cuffs, cuff pressure vari-
ations are expected to be greater in these cuffs, which
could decrease their efficacy. To determine the impact of
polyurethane on variations in cuff pressure in intubated
critically ill patients, Nseir et al. [18] continuously
recorded for 24 h cuff pressure in 76 patients, including
26 with polyvinyl chloride (PVC), 22 with cylindrical
polyurethane (CPU) and 28 with tapered polyurethane
(TPU)-cuffed tracheal tubes. Although polyurethane did
not impact variations in cuff pressure, microaspiration of
gastric contents, as determined by pepsin contents in
proximal airways, was less frequent in patients intubated
with polyurethane-cuffed (either cylindrical or tapered)
tubes compared with patients intubated with PVC-cuffed
tubes, confirming the potential usefulness of these
devices.
Non-invasive ventilation (NIV) has been described
among other measures as a potential strategy to prevent
VAP and the recommendation to use NIV whenever
possible has been incorporated in guidelines for VAP
prevention [19]. To compare the characteristics of pneu-
monia cases associated with different types of ventilation
and the spectrum of associated pathogens, Kohlenberg
et al. [20] analysed the pooled data of 400 German
ICUs participating in the German nosocomial infection
surveillance system with respect to three categories of
nosocomial pneumonia: pneumonia associated with
invasive mechanical ventilation (MV), pneumonia asso-
ciated with NIV and pneumonia not associated with
ventilation. The study included 779,500 patients, totaliz-
ing 1,068,472 invasive MV days and 101,569 NIV days; a
total of 6,869 cases of pneumonia were reported. The
mean pneumonia incidence densities were 1.58 and 5.44
cases per 1,000 ventilator days for NIV and invasive MV,
respectively. Pneumonia cases associated with invasive
MV were younger, had a longer ICU stay before onset of
pneumonia and were more often associated with gram-
negative bacteria than cases associated with NIV; how-
ever, there were no differences in the proportion of
secondary sepsis and death.
The concept of bundles, a series of coordinated
interventions devoted to VAP prevention through guide-
line implementation, was proposed by a European task
force in order to rationalize prevention practices [21]. The
resulting VAP care bundles were non-ventilatory circuit
changes unless specifically indicated, alcohol hand
hygiene, appropriately educated and trained staff, incor-
poration of sedation control and weaning protocols into
patient care, and oral care with chlorhexidine.
Treatment of VAP
The appropriateness of empirical antimicrobial therapy
for VAP is a determinant for patient outcome and is
mostly related to difficult-to-treat pathogens, such as
Pseudomonas aeruginosa, Acinetobacter baumannii and/
or oxacillin-resistant Staphylococcus aureus. In a large
cohort study on 218 patients with microbiologically
documented VAP, empirical antimicrobial therapy was
inappropriate in 40% of the patients with VAP due to
difficult-to-treat bacteria and 5% in cases of non-difficult-
to-treat bacteria (p = 0.001) [22]. In almost half of the
cases, inappropriate empirical antimicrobial therapy for
difficult-to-treat bacteria was due to non-adherence to the
local guidelines, suggesting some room for improvement
by implementing educational programs.
Emergence of multidrug-resistant strains in ICUs has
renewed interest in colistin, which often remains the only
available antimicrobial agent active against resistant
P. aeruginosa or A. baumannii. In a study performed in
ventilated piglets with inoculation pneumonia caused by
P. aeruginosa, Lu et al. [23] showed high colistin lung
tissue deposition following nebulization, contrasting with
the absence of any detectable deposition following
intravenous administration. In the aerosol group, the high
lung deposition was associated with rapid and efficient
bactericidal activity. Interestingly, colistin distal lung
deposition decreased with severity of pneumonia and
aeration loss, as shown previously with nebulized ceft-
azidime [24].
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Epidemiology
Infection is the most frequent cause of acute respiratory
distress syndrome. However, little is known about the
influence of infection sites on ARDS. To assess the
associations between infection sites and ARDS develop-
ment and mortality in critically ill infected patients, Sheu
et al. [25] prospectively followed 1,973 consecutive
patients admitted to ICUs with bacteraemia, pneumonia
or sepsis. During follow-up, 549 patients developed
ARDS and 212 of them died within 60 days. On multi-
variate analysis, lung was the only infection site
associated with increased ARDS risk [adjusted odds ratio
(OR) 3.49]. Urinary tract (adjusted OR 0.43), skin/soft
tissue (adjusted OR 0.64) and unknown-site infections
(adjusted OR 0.38) were associated with decreased risk.
No association was found between individual infection
site and ARDS mortality.
The excess risk of death attributable to VAP varies
considerably across studies, from 0 to 50% [26]. Several
factors contribute to this variability, including definitions,
case-mix, causative microorganisms, treatment adequacy
and statistical methodology. Using a multistate progres-
sive disability model that appropriately handled VAP as a
time-dependent event in a high-quality database of 2,873
mechanically ventilated patients, Nguile-Makao et al. [27]
showed that VAP attributable mortality (VAP-AM) was
8.1% overall. VAP-AM varied widely with case-mix,
severity at admission, time to VAP onset, and severity of
organ dysfunction at VAP onset. Bacterial resistance did
not affect VAP-AM. These results are consistent with the
10.6% value obtained in five German ICUs using a
multistate PD model [28].
Infections
Diagnosing bloodstream infections has always been
associated with a diagnostic delay of at least 24 h. Con-
sidering the consequences of rapid and appropriate
antimicrobial therapy in patients with ICU-acquired bac-
teraemia, diagnostic methods that reduce this diagnostic
delay might significantly enhance the quality of patient
care. Conventional microbiological methods depend on
the growth of bacteria, which will take hours to yield a
positive signal. Yet, with detection of bacterial DNA with
polymerase chain reaction (PCR) such a signal could, in
theory, be obtained within minutes. Two recent studies
addressed this issue. In one study of 453 blood samples in
108 patients, PCR resulted in a higher positivity rate (114
samples) than conventional blood cultures (58 samples),
but discordant results occurred in 18 of these 58 samples
[29]. In the other study, of 143 patients with severe sepsis
and 63 surgical controls, PCR yielded more positive
results (34.7 vs. 16.5%), but PCR positivity was only
obtained in 70% of the samples with growth in blood
cultures. Yet PCR positivity (with negative results from
culture) correlated with disease severity [30]. Another
innovative approach for diagnosing ICU-acquired infec-
tions is F-18-fluorodeoxyglucose positron emission
tomography (FDG-PET CT). In 33 patients with a clinical
suspicion of ICU-acquired infection, the diagnostic
accuracy of PET-CT, when added to standard diagnostic
procedures, was estimated to be 91%, with 79% speci-
ficity and 100% sensitivity [31]. Therefore, although
promising, the clinical values of the PCR-based detection
of bacterial DNA in blood samples and of FDG-PET CT
remain to be determined.
Transmission of multi-resistant bacteria is increasingly
creating difficult-to-treat infections, and effective infec-
tion control measures are needed. The role of antibiotics
in the transmission is difficult to quantify. Temporary use
of a certain class on antibiotics (cycling) has been pro-
posed as a measure to reduce antibiotic selective pressure,
as compared to a more chaotic approach of antibiotic
prescription. Yet, predominant use of fluoroquinolones
had devastating effects on the acquisition of resistance to
cephalosporins and fluoroquinolones by Enterobacteria-
ceae in a Dutch ICU [32]. In contrast, implementing
quality improvement measures over a period of 8 years
(such as ICU relocation, antibiotic stewardship, dedicated
infection control nurses and alcohol-based hand rub
solution) was associated with a decrease in the endemic
rates of MRSA in an Australian ICU [33]. Daily skin
cleansing with chlorhexidine has been associated with
lower infection rates and lower transmission rates of
antibiotic-resistant bacteria. Yet, when analysed in a
pragmatic design in a surgical ICU, this intervention
failed to reduce rates of central line-associated bacterae-
mias, although the blood culture contamination rate did
decline [34].
Careful preparation is needed when an influenza
pandemic or other mass disaster is expected. Recom-
mendations for ICU preparation have been formulated, in
order to minimize the inevitable mortality associated with
such circumstances [35]. During an influenza outbreak
many patients will need ICU admission because of severe
community-acquired pneumonia. Distinction between
patients with viral, bacterial or mixed infection is relevant
for optimizing treatment strategies. In a small subset of 25
patients, CRP, and to a lesser extent procalcitonin,
assisted in distinguishing pneumonia due to bacterial
causes and H1N1 influenza [36]. Currently, moxifloxacin
is frequently used to treat severe community-acquired
pneumonia and the main pharmacokinetics/pharmacody-
namics parameter predicting its clinical efficacy is the
AUC/MIC. It was demonstrated that when using 400 mg
moxifloxacin once daily in critically ill patients this
parameter can be considerably lower than in healthy
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volunteers, suggesting that dosage adjustments are needed
[37].
There are differences in the literature regarding the
impact of nosocomial infections on attributable mortality
and resource consumption. In a cohort of 2,392 patients
from 34 Austrian ICUs, with a length of stay (LOS)
greater than 2 days, 683 (28.6%) developed at least one
nosocomial infection [38]. The most common infection
was pneumonia (n = 456), followed by central venous
catheter (CVC) infections (n = 101). Risk-adjusted
mortality rates (standardized mortality ratios) were sig-
nificantly increased for infected patients [0.91 (0.83–0.99)
vs. 0.68 (0.61–0.74)]. Significant attributable risk-adjus-
ted mortality was found for patients with pneumonia,
combined infections (both 32%) and CVC-related infec-
tions (26%). LOS in the ICU increased significantly for
all infections. All infections were associated with
increased resource consumption. The authors suggested
that effective infection control measures could improve
both clinical outcome and use of ICU resources.
Low monocyte human leukocyte antigen-DR expres-
sion (mHLA-DR) has been proposed as a global
biomarker of sepsis immunosuppression. A very recent
study included 209 septic shock patients for whom HLA-
DR was measured by flow cytometry at days 3–4 and 6–9
after the onset of shock [39]. This study first confirmed
that non-survivors (n = 51) exhibited lower mHLA-DR
values, expressed as means of fluorescence intensities,
than survivors (n = 102) (33 vs. 67). It also showed that
patients who developed nosocomial infections exhibited
lower mHLA-DR values than those who did not. Persis-
tent low mHLA-DR (B54) was independently associated
with nosocomial infection occurrence after adjustment for
clinical parameters.
Cardiovascular and haemodynamics
Haemodynamic management of severe sepsis
Restoring blood pressure is one of the main aims of the
management of septic shock. As recommended, low
blood pressure should be first restored, as early as possi-
ble, by fluid loading, followed, in case of failure, by the
administration of vasopressors.
Whether beneficial effects of fluid loading are only
related to improvement in global haemodynamics or
might be related to improved local microcirculation
remains unclear. It has been recently shown that fluid
administration improved microvascular perfusion in the
early but not late phase of sepsis [40]. The proportion (%)
of perfused small vessels increased from 65 (60–72) to 80
(75–84) (p \ 0.01) in the early phase and from 75
(66–80) to 74 (67–81) (p = not significant, ns) in the late
phase. This beneficial effect of fluid administration in
severe sepsis was independent of global haemodynamic
(cardiac index, mean blood pressure) effects and the type
of solution.
The choice of vasopressor is still unclear. Maybauer
and Walley [41] advocate the concept of tailored therapy.
In terms of choosing a vasopressor in patients with septic
shock, they wrote that a ‘‘winner-takes-all’’ approach is
likely not the way to go. The recently published literature
does not give definitive results in favour of one particular
vasopressor. In addition to the need of restoring blood
pressure, intensivists should also consider the clinical
context: arrhythmia, lactate level, cardiac failure. Thus
norepinephrine may be a better vasopressor in cases of
arrhythmia or elevated lactate level. Arginine vasopressin
might have an additive value when catecholamines failed
to restore blood pressure. In advanced vasodilatory shock
already receiving catecholamines, two arginine vaso-
pressin (AVP) dose regimens were recently tested on the
haemodynamic response, catecholamine requirements,
AVP plasma concentrations and organ function [42].
Patients requiring more than 0.6 lg/kg/min of norepi-
nephrine received a supplementary AVP infusion either at
0.033 IU/min (n = 25) or 0.067 IU/min (n = 25). The
latter dose (0.067 IU/min) restored cardiovascular func-
tion more effectively than AVP at 0.033 IU/min. AVP
administration was associated with a decrease in heart
rate, norepinephrine requirement, lactate and an increase
in blood pressure.
Pulse pressure variation and fluid responsiveness
Pulse pressure variation (PPV) is increasingly used to
predict fluid responsiveness in mechanically ventilated
patients. However, the impact of tidal volume (VT) and
airway driving pressure (Ppla-PEEP) remains unclear.
Effect of fluid challenge was assessed in 57 mechanically
ventilated and sedated patients with signs of hypoperfu-
sion (oliguria and catecholamine use) and requiring
cardiac output (CO) measurement [43]. Most of the
patients (71%) were responders. At baseline, central
venous pressure (CVP) was lower and PPV was higher in
responders. The areas under the receiver operating char-
acteristics (ROC) curves were similar with PPV and CVP
(0.76). Furthermore, in patients mechanically ventilated
with low VT, PPV values less than 13% did not rule out
fluid responsiveness, especially when (Pplat-PEEP) was
no greater than 20 cmH2O.
Risk stratification of acute myocardial infarction
admitted in ICU
ARIAM is a Spanish database that prospectively collected
data from 6,458 ICU patients admitted for acute
myocardial infarction (AMI) [44]. Main demographic
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parameters were the following: 77% males, age 65 years,
APACHE-II score 9 points and ICU mortality 8.9%. In
multivariate analysis, ICU mortality was related to
APACHE-II (OR 1.16), age (OR 1.05), gender (OR 1.64),
previous AMI (OR 1.57), anterior AMI (OR 2.05) and
delay longer than 180 min (OR 1.37) and Killip class.
Evaluation of haemodynamic alterations
Fluid management: can we better predict
fluid requirements?
Techniques predicting the response to fluids are becoming
more and more popular. Passive leg raising is based on
the fact that rapid postural changes induce an acute
increase in ventricular preload which would lead to an
increase in cardiac output in patients who will subse-
quently respond to fluid administration [45]. However, to
be effective this test should effectively increase preload. It
has been shown that the increase in cardiac output is
dependent on the amount of blood mobilized, and that
raising the legs together with changing torso position
from 30 to 0 maximally increases preload [46]. However,
even when fluid mobilization is maximal it can still be
insufficient to effectively increase preload (such as in
patients with increased intrathoracic pressure or severe
peripheral vasoconstriction). In order to ensure that pre-
load is effectively manipulated, Lakhal et al. [47]
elegantly proposed to use the changes in CVP induced by
passive leg raising. They hypothesized that an absence of
change in CVP would suggest that the change in preload
was insufficient, so that no conclusions can be drawn
based on the test. In this multicentric trial (four centres),
the authors investigated 102 patients estimated to need a
fluid challenge. All patients were under mechanical ven-
tilation and equipped with a haemodynamic monitoring
device. The passive leg raising test had a satisfactory
predictive value for fluid responsiveness, as assessed by a
ROC curve area of 0.89. When changes in CVP were
considered, the ROC curve area was higher in the 49
patients experiencing an increase in CVP by at least
2 mmHg than in the others (0.98 vs. 0.83). These data
suggest that this easy to apply measurement can be used
to improve the predictive value of passive leg raising test.
Another important aspect in this test is the method
used to determine the changes in cardiac output. Lakhal
et al. also showed that cardiac output should be measured
as indirect assessment of changes in pulse pressure gave
lower predictive values (0.74 vs. 0.89). However, invasive
or semi-invasive monitoring devices are not always
available in these patients. Benomar et al. [48] investi-
gated whether measurements of cardiac output with
bioreactance, a totally non-invasive device, could be used.
The authors investigated 75 consecutive patients after
cardiac surgery. In the postoperative period, all patients
underwent a passive leg raising test and a subsequent fluid
challenge. The authors first determined the least minimal
significant change in cardiac output that was found to be
at 8.9%. Using this cut-off value during passive leg
raising test, the authors observed that the test had 68%
sensitivity and 95% specificity for detecting a positive
response to fluid challenge.
Another aspect of management that is often neglected
is the risk of developing hypovolaemia when fluids are
withdrawn during haemofiltration/haemodialysis. Guiotto
et al. [49] used echocardiography to evaluate respiratory
variations before and after fluid removal by slow contin-
uous haemofiltration in 24 patients with decompensated
heart failure. Overall fluid withdrawal of 5.8 L over 20 h
was well tolerated, as mean arterial pressure and heart rate
remained unaltered. Respiratory variations in inferior vena
cava diameter increased significantly but reached 30%
only in the two patients developing hypotension. Unfor-
tunately, this study investigated patients only before and at
the end of fluid withdrawal, and sequential measurements
were lacking. Hence, it was not feasible to evaluate whe-
ther respiratory variations in inferior vena cava occurred
well before occurrence of hypotension so that they could
be used as a warning signal or whether they occurred only
when symptomatic hypovolaemia already developed.
A systematic review of the published evidence on the
ability of passive leg raising-induced changes in cardiac
output (PLR-cCO) and in arterial pulse pressure (PLR-
cPP) to predict fluid responsiveness was published in the
September issue [50]. Nine articles including a total of 353
patients were included in the final analysis. The pooled
sensitivity and specificity of PLR-cCO were 89.4%
(84.1–93.4%) and 91.4% (85.9–95.2%), respectively.
Diagnostic odds ratio was 89.0 (40.2–197.3). The pooled
area under the receiver ROC curve was 0.95 (0.92–0.97).
The pooled difference in mean PLR-cCO values between
responders and non-responders was 17.7% (13.6–21.8%).
No significant differences were identified between patients
adapted to ventilator versus those with the persistence of
spontaneous breathing and between patients in sinus
rhythm versus those with arrhythmias. The pooled differ-
ence in mean PLR-cPP values between responders and
non-responders was 10.3% (6.5–14.1%). The authors
concluded that passive leg raising-induced changes in
cardiac output can reliably predict fluid responsiveness
regardless of ventilation mode and cardiac rhythm, and can
be recommended for routine assessment of fluid respon-
siveness in the majority of ICU patients. The PLR-cCO has
a significantly higher predictive value than the PLR-cPP.
Devices and techniques
Different technologies can be used to estimate CO.
Galstyan et al. [51] evaluated the ability of an ultrasound
dilution technique to measure cardiac output and to
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estimate intrathoracic blood volumes. In this method an
external loop in which blood circulates at constant flow is
used to transiently make blood circulate. Injection of
small saline bolus is used to measure dilution, the changes
in ultrasound transmission properties induced by this
bolus being detected in the external loop. This technique
also allows one to compute central blood volume.
The authors measured cardiac output and intrathoracic
volumes in 30 patients with transpulmonary thermodilu-
tion (PiCCO, Pulsion) and ultrasound dilution (Transonic
Systems). Regarding cardiac output measurements, there
was very good agreement between the two methods, with
a bias of 0.03 L/min and a percentage error of 20%.
However, measurements of global end diastolic volumes
with PiCCO were 2.5 times larger than ultrasound-derived
central blood volumes. In the absence of alternate mea-
surement of heart volumes, the authors speculated that the
ultrasound dilution technique measured left heart cham-
bers while global end diastolic volumes include left and
right heart chambers and large vessels. Additional studies
are required to confirm this hypothesis and to validate this
measurement as an estimate of left heart chambers.
Impact of fluid type
The impact of the type of fluids on haemodynamics and
on potential side effects is still a matter of debate. In a
randomized trial, Trof et al. [52] evaluated the haemo-
dynamic response to fluid challenge with colloids
(n = 24) or crystalloids (n = 24) in a cohort of 48 criti-
cally ill patients, including 24 septic and 24 non-septic
patients. Cardiac output and global end diastolic volume
were measured by using transpulmonary thermodilution.
The authors observed that cardiac index increased more
with colloids than with crystalloids (12 vs. 2%, p \ 0.05)
and this was related to a greater increase in preload as
estimated by a greater increase in central venous pressure
and in global end diastolic volume (both p \ 0.05). There
were no differences between septic and non-septic
patients. These data confirm that for a given volume,
plasma expansion induced by colloids is greater than with
crystalloids. However, these observations were restricted
to a 90-min period and the duration of plasma expansion
with the two solutions was not evaluated.
Schortgen et al. [53] evaluated the impact of oncocity
of infused fluids on the development of secondary ARDS.
The authors had a retrospective look at a large database of
prospectively collected data from patients receiving fluid
administration during a 4-week observation period. After
exclusion of patients presenting ARDS at inclusion, the
authors evaluated the development of secondary ARDS.
Patients were separated according to the predominant type
of fluids received, hypooncotic for crystalloids and low
concentrations colloids (such as 5% albumin solutions) or
normo- or hyperoncotic fluids (20% albumin, starches).
Nine percent of the 905 patients developed secondary
ARDS, with no difference between hypo- and normo/
hyperoncotic group (10.4 vs, 7.7%, p = ns). It is possible
that the trial was underpowered to detect a difference of
this magnitude; however, other factors such as sepsis or
positive fluid balance were identified to be associated with
the onset of secondary ARDS. This study does not iden-
tify oncocity of fluid infused as a factor associated with
development of secondary ARDS.
Resuscitating the microcirculation
The role of microcirculatory alterations in sepsis and
in their association with outcome has been largely
demonstrated [54, 55]. However, the effects on the mi-
crocirculatory alterations of various interventions, and in
particular fluids, remains not well defined. This issue was
amply covered this year in Intensive Care Medicine. Boldt
and Ince [56] published a systematic review on the effects
of fluids on the microcirculation. They observed that many
experimental trials point out that colloids administration
may be associated with a greater improvement in micro-
circulatory perfusion than crystalloid administration. They
also reported that human data were lacking at the time of
their review. Intensive Care Medicine later published two
interesting trials reporting the effects of fluids on sublin-
gual microcirculation in patients with severe sepsis. In a
series of 60 patients, Ospina-Tascon et al. [40] showed that
fluid administration markedly improved the microcircu-
lation in patients in the early phase of sepsis (defined as
within 24 h of the diagnosis of sepsis), but did not affect
microcirculation at later stages (after 48 h). There were no
differences between crystalloid or 4% albumin adminis-
tration. Interestingly, the microcirculatory effects could
not be predicted by looking at the global haemodynamic
response to fluids. Pottecher et al. [57] also evaluated the
impact of fluids on the microcirculation. In a series of 25
patients with severe sepsis admitted for less than 24 h, the
authors performed a passive leg raising test followed by
administration of crystalloids in two steps. All patients
were predicted to be fluid responders before fluid admin-
istration (based on selection by passive leg raising test).
They observed that passive leg raising test significantly
improved the microcirculation and that a similar effect
was observed with the first aliquot of fluids (computed to
be equivalent to the amount of fluid mobilized by leg
raising). These effects were associated with an increase in
cardiac index. Interestingly, the second part of the fluid
challenge (the subsequent 200-mL aliquot) was not asso-
ciated with further changes in microcirculatory perfusion,
while cardiac index further increased. As mentioned by an
accompanying editorial [58] the aspects common to the
two trials were emphasized (relative lack of dependency
from cardiac output, importance of fluids in the early
phase). It was also noticed that we still need more evidence
202
to determine whether the type of fluid may be associated
with a different response.
Another aspect of microvasculature was investigated
by Georger et al. [59]. These authors investigated the
effects of correcting hypotension on microvascular
vasoreactivity in 28 patients with septic shock. The latter
was evaluated by using a transient occlusion test and
measuring microvascular oxygen saturation by near-
infrared spectroscopy. The authors observed that an
increase in mean arterial pressure from 54 to 77 mmHg
also increased basal microvascular O2 saturation from 75
to 78% (p \ 0.05) but the clinical significance of these
changes remains quite limited. More interestingly, the
recovery slope increased by 50% (p \ 0.05). These
effects suggest either an intrinsic effect of the vasoactive
agent (norepinephrine) or, more likely, a beneficial
impact of restoring a minimal perfusion pressure on
microvascular responsiveness. These results should be
looked at cautiously, as there was no proof that these
effects on near-infrared spectroscopy derived variables
were associated with improved microvascular perfusion.
Long-term effect of goal-directed therapy in high-risk
surgery patients
Many trials have shown that perioperative haemodynamic
optimization is accompanied by an improvement in short-
term outcome. However the question remains whether
this was just a transient phenomenon (benefit lost after a
few weeks) or whether long-term benefit could also be
observed. Rhodes et al. [60] evaluated the very long-term
impact on outcome of perioperative haemodynamic
optimization in a cohort of patients in whom short-term
beneficial effects on 28-day survival had been reported.
Fifteen-year follow-up was obtained in 106 of the 107
patients included in the original cohort. At 15 years, 21%
of the intervention arm and 8% of the control group were
still alive (p = 0.09) while median survival time was
significantly longer in the intervention cohort (1,781 vs.
674 days, p \ 0.005). Multivariate analysis identified
goal-directed therapy, age and avoidance of cardiac
complications as independent factors associated with
better outcome.
Can we improve resuscitation procedures?
Cardiopulmonary resuscitation remains associated with
variable success, and improved resuscitation procedures
would be more than welcome. The use of an automated
load distribution chest compression device has been
suggested to potentially improve quality of resuscitation.
However, human data are still lacking. Duchateau et al.
[61] evaluated the effects of such a device on arterial
pressure during cardiopulmonary resuscitation (CPR) in
29 patients with out-of-hospital cardiac arrest. Compared
with manual CPR, automated CPR was associated with an
increase in systolic (from 72 to 106 mmHg, p \ 0.05) and
diastolic (from 17 to 23 mmHg, p \ 0.05) pressures.
However, there was no change in end-tidal CO2, sug-
gesting that the impact of this intervention on cardiac
output may be limited. Although promising, these results
need to be evaluated in a larger cohort of patients.
Critical care organization and outcome
Early management of critically ill patients has been advo-
cated by three manuscripts in Intensive Care Medicine this
year. Konrad et al. [62] evaluated the impact of a medical
emergency team (MET) implementation on the incidence
of cardiac arrests and hospital mortality. In a before/after
trial they compared outcomes in 203,892 patients admitted
before MET implementation, with outcomes of 73,825
patients managed after MET implementation. Cardiac
arrests per 1,000 admissions decreased from 1.12 to 0.83,
OR 0.74 (95% CI 0.55–0.98, p = 0.035). MET imple-
mentation was associated with a reduction in total hospital
adjusted mortality by 10%, OR 0.90 (95% CI 0.84–0.97,
p = 0.003). Hospital mortality was also reduced for med-
ical patients by 12%, OR 0.88 (95% CI 0.81–0.96,
p = 0.002) and for surgical patients not operated upon by
28%, OR 0.72 (95% CI 0.56–0.92, p = 0.008). Thirty-day
and 180-day mortality rates were 25 and 37.5%, respec-
tively, during the pre-MET period and 7.9 and 15.8%,
following MET.
The relationship between ICU admission time and in-
hospital mortality has been studied in the 149,894 patients
included in the Dutch national ICU registry from 2002 to
2008 [63]. The relative risk (RR) for mortality outside
office hours was 1.059 (1.031–1.088). During the week-
end the RR was 1.103 (1.071–1.136) in comparison with
the rest of the week.
Several studies have been published on various aspects
of quality of care and ICU-acquired events in the critically
ill. Seguin et al. [64] prospectively evaluated the effec-
tiveness of simple daily sensitization of physicians to the
duration of central venous and urinary tract catheterization
(UTC) and related infection rates. During the intervention
period, a red square, added to the patient’s daily care sheet,
questioned the physician about the utility of the CVC and/
or UTC. If the response was ‘‘No’’, the CVC and/or the
UTC were removed by a nurse. The duration of catheter-
ization was significantly reduced [period 1, n = 676; 5
(3–9) days, period 2, n = 595; 4 (3–7) days, p \0.001, for
CVC, 5 (3–11) days to 4 (3–8) days, for UTC]. The inci-
dence and density incidence of CVC infection decreased
in period 2 compared with period 1 (from 1.8 to 0.3%,
p = 0.010, and from 2.8 to 0.7/1,000 CVC-days,
p = 0.051), whereas UTC infections were not
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significantly different (4.3 to 3.0%, p = 0.230, and 5.0 to
4.9/1,000 UTC-days, p = 0.938, respectively).
Knowing the reasons for ICU admission during
pregnancy, delivery and puerperium has important orga-
nization implications. Zwart et al. [65] collected
prospective data on ICU admissions in all 98 Dutch
maternity units. There were 847 obstetric ICU admissions
in 358,874 deliveries, the incidence being 2.4 per 1,000
deliveries. Twenty-nine maternal deaths occurred, result-
ing in a case fatality rate of 1 in 29 (3.5%). Most frequent
reasons for ICU admission were major obstetric haemor-
rhage (48.6%), hypertensive disorders of pregnancy
(29.3%) and sepsis (8.1%). Assisted ventilation was nee-
ded in 34.8%, inotropic support in 8.8%. Initial antenatal
care by an obstetrician was associated with a higher risk
and home delivery with a lower risk of ICU admission.
Iatrogenic errors received growing attention in the last
few years with the intent of establishing organization plans
for their identification and correction. Mercier et al. [66]
determined the incidence, risk factors, severity and pre-
ventability of iatrogenic events (IEs) as a cause of ICU
admission. Admission to the ICU for IE concerned 103
(19.5%) out of 528 patients. IE was considered as probably
preventable in 73.8% of cases. Length of stay was higher
in IE patients. Catecholamine drugs, blood transfusion and
parenteral nutrition were more frequently required in the
IE group. Severity, surgical admissions and admission for
shock were more frequent in the IE group.
Ford et al. [67] assessed whether simulation-based
learning reduced medication error rates in critically ill
patients. Twenty-four nurses were observed administering
medications. Documentation included drug name, dose,
route, time and technique during observation and active
medication orders in the patient’s chart. Interventions
were two types of educational sessions with content
developed from baseline medication administration error
data: simulation-based training for critical care unit
(CCU) nurses and a didactic lecture for medical intensive
care unit (MICU) nurses. Quizzes completed before and
after the interventions were used to assess knowledge.
After the simulation-based educational intervention in the
CCU, medication administration error rates decreased
from 30.8 to 4.0% (p \ 0.001) in the initial post-inter-
vention observation and were sustained in the final post-
intervention observation (30.8 to 6.2%; p \ 0.001).
Intensive care medicine has developed rapidly and to a
considerable extent throughout the past 10–15 years.
Hence, it is mostly important to implement and adapt
programs for training the physicians. In this context, the
generation of guidelines is increasingly challenging. A
critical appraisal of the quality of these guidelines was
presented within a special review [68]. The investigators
concentrated on the evaluation of the strength of recom-
mendation from a total of 24 clinical practice guidelines
(CPG) over a time from 1966 until 2008. Specific aims
were clarity, scope/purpose, rigour of development,
editorial independence, stakeholder involvement, and
applicability of the recommendations. The investigators
found that 36% of recommendations are supported by
high-quality evidence, thus recommending appraisal of
CPG quality and the caliber of supporting evidence prior
to applying recommendations.
A special supplement of Intensive Care Medicine
concentrated on a similar issue, but with a specific aim: a
group of authors gave recommendations for standard
operating procedures (SOP) for ICU and hospital prepa-
rations for an influenza epidemic or mass disaster, which
was broadly discussed in 2010 due to the H1N1 pande-
mia. This supplement is highly recommended to those
who are involved in this issue, and it is far beyond the
scope of this review to cover all single topics. Roughly,
the key issues were coordination and communication
[69], surge capacities and infrastructure [70], collabora-
tion between the ICU and other key stakeholders [71],
manpower [72], essential equipment, pharmaceuticals and
supplies [73], protection of patients and staff [74], critical
care triage [75], protocols and procedures [76] and
emergency executive control groups [77].
Outcomes
In a retrospective analysis, Polverino et al. [78] retrospec-
tively analysed the time course of patients’ characteristics,
clinical outcomes and medical staff utilization in five Ital-
ian respiratory ICUs (RICUs) by comparing three periods
of five consecutive years (from 1991 to 2005). Over the
different time periods, the number of co-morbidities per
patient and the previous ICU stay increased over time. The
doctor-to-patient ratio significantly decreased over time,
whereas the physiotherapist-to-patient ratio mildly
increased. The overall weaning success rate decreased.
Fewer patients were discharged to home and more patients
to nursing home, acute hospitals and rehabilitative units.
The mortality rate increased over time (from 9 to 15%).
Two studies have assessed qualitative outcomes in
critically ill patients. In a two-step trial comprising a
phase of item generation conducted in one ICU and a
phase of psychometric evaluation during a multicentre
prospective cohort study in 14 ICUs, Kalfon et al. [79]
developed and validated the IPREA questionnaire for the
assessment of discomfort perceived by patients related to
their ICU stay. On the day of ICU discharge, a nurse
asked 868 patients to rate the severity of 16 discomfort
sources, from 0 to 100. Ten per cent of patients were
randomly chosen to be questioned again to assess the
reproducibility. The highest scores were for sleep depri-
vation, being restrained by tubing, wires, and cables, pain
and thirst.
Vainiola et al. [80] compared the EQ-5D and 15D in
critically ill patients. A total of 929 patients filled in both
the EQ-5D and 15D HRQoL instruments 6 and 12 months
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after treatment at an intensive care or high-dependency
unit. The utility scores produced by the instruments and
their distributions were different. Agreement between the
instruments was only moderate. The 15D appeared more
sensitive than the EQ-5D both in terms of discriminatory
power and responsiveness.
Education
The European Society of Intensive Care Medicine through
the Competency Based Training in Intensive Care medi-
cine collaboration (CoBaTrice) has recently developed the
international standards for programmes of training in
intensive care medicine for Europe [81]. Growing impor-
tance and emphasis has been given to professionalism.
However, insight into the elements of professionalism as
perceived relevant for intensivists from the fellows’ (resi-
dents) view, and how these are taught and learned, is
limited. In order to address these issues, van Mook et al.
[82] carried out a nationwide study (2007–2008) among
intensive care medicine fellows in The Netherlands. Ninety
intensive care medicine fellows were sent a questionnaire
pertaining to quantity and quality of formal and informal
learning methods. Analyzing the answers of the 75.5%
(n = 68) respondents, van Mook et al. concluded that
almost all elements of professionalism were considered
relevant to intensivists’ daily practice and that learning by
personal experiences and informal ways quantitatively and
qualitatively plays a more important, and more valued role
than learning by formal teaching methods.
Sandroni et al. [83] identified factors associated with
candidate outcome in the European Resuscitation Council
(ERC) advanced life support (ALS) provider courses.
Candidates [n = 269 (95.1%)] who passed were younger
and attained a higher pre-course score than those who
failed the final evaluation. A higher pre-course score [OR
1.18 (95%CI 1.09–1.28)] and a basic life support (BLS)
certification [OR 5.00 (95%CI 1.12–22.42)] were inde-
pendent predictors of candidate success, while older age
was associated with a significantly higher risk of failing
[OR 0.90 (95%CI 0.83–0.97)].
Methodology plays an important role in education and
research evaluation. The January issue of Intensive Care
Medicine contained a review on meta-analysis [84].
Despite the validity of this approach, which combines
evidence from multiple trials, meta-analyses of studies
with substantial heterogeneity among patients within tri-
als (a common condition in intensive care) can lead to
incorrect conclusions if performed by using aggregate
data. Use of individual patient data (IPD) can avoid this
concern, increase the power of a meta-analysis and is
useful for exploring subgroup effects. Barriers exist to
IPD meta-analysis, most of which are overcome if clinical
trials are designed to prospectively facilitate the
incorporation of their results with other trials. Authors
review the features of prospective IPD meta-analysis and
identify those of relevance to intensive care research. As a
concluding remark, the authors suggested that the poten-
tial effect of variations in baseline risk and intercurrent
care is sufficiently large in intensive care to threaten the
validity of any meta-analysis based in aggregate data.
This article has an accompanying editorial comment [85].
Another interesting review was published on a statis-
tical approach recently applied in the field of intensive
care medicine, often used to correct the lack of random-
ization in clinical studies: the propensity score (PS)
methods [86]. PS methods have been increasingly used in
the last 10 years. In this review article, the authors briefly
explain the theory of propensity scores, assess the use and
the quality of reporting of PS studies in intensive care and
anaesthesiology, and finally they evaluate how past
reviews have influenced the quality of the reporting.
Forty-seven articles published between 2006 and 2009 in
the intensive care and anaesthesiology literature were
evaluated. Of the 47 articles reviewed, 26 used matching
on PS, 12 used stratification on PS and 9 used adjustment
on PS. The method used was reported in 81% of the
articles, and the choice to conduct a paired analysis or not
was reported in only 15%. The comparison with the
previously published reviews showed little improvement
in reporting in the last few years. The authors also pro-
vided some recommendations to investigators in order to
improve the reporting of PS analyses. It was concluded
that the quality of reporting PS in intensive care and
anaesthesiology literature should be improved.
Haematology
In a prospective, observational, multicentre cohort study,
investigators of the ANZICS Clinical Trials Group
assessed the relationship between clinical practice and
national guidelines for the transfusion of red blood cells
(RBCs), fresh frozen plasma (FFP), platelets and cryo-
precipitate in Australian and New Zealand ICUs [87]. A
total of 874 patients receiving any type of blood trans-
fusion were studied. The proportions of transfusions not
adherent to guidelines were 2% for RBC, but 53% for
platelets, 29% for FFP and 88% for cryoprecipitate (RBC
vs. other transfusion p \ 0.001 for all).
To compare evolution in organ dysfunction (OD)
between haematologic malignancy patients with and
without bacterial infection (BI), Vandijck et al. [88]
performed a retrospective analysis in haematologic
malignancy patients admitted to their ICU between 2000
and 2006. Patients admitted because of BI had more
severe OD on day 1, but a more rapidly reversible OD
within the first 3 days and a lower in-hospital (43.2 vs.
62.9%, p \ 0.001) and 6-month mortality (52.1 vs.
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71.7%, p \ 0.001) than patients with other complications.
BI remained independently associated with a lower risk of
death (OR 0.20, 95% CI 0.1–0.4, p \ 0.001).
The October issue of Intensive Care Medicine pub-
lished an interesting article on critical care management
of patients with haemophagocytic lymphohistiocytosis
(HLH) [89]. A retrospective search (from 1998 to 2009) on
this life-threatening condition associated with multiple
organ dysfunction was performed in a medical ICU. A
total of 72 patients were identified as having an HLH, and
data on 56 patients with complete follow-up were repor-
ted. Precipitating factors consisted of 43 tumoral causes,
13 non-viral infections and 10 viral infections. Underlying
immune deficiency was present in 38 (67.8%) patients.
Etoposide was used in 45 patients, corticosteroids in 31
and intravenous immunoglobulins in 3. Hospital mortality
was 51%. By multivariate analysis, factors associated with
increased hospital death were shock at ICU admission (OR
4.33) and platelet count below 30 9 109/l (OR 4.75). B
cell lymphoma and Castleman’s disease were associated
with increased hospital survival. It was concluded that
aggressive supportive care combined with specific treat-
ment of the precipitating factor can produce meaningful
survival in these patients.
Ventilatory approach of haematological patients out-
side the ICU might be important. Squadrone et al. [90]
randomized haematological patients in the wards
with acute respiratory failure to received either oxygen
(n = 20) or oxygen plus continuous positive airway
pressure (CPAP, n = 20). CPAP reduced the relative risk
for intubation.
Nutrition and metabolism
Enteral nutrition
Enteral feeding is a cornerstone of ICU nutrition, and
documentation around safety is important. In the REG-
ANE study Montejo et al. [91] demonstrated that a gastric
residual volume of 500 mL is not associated with a higher
complication rate as compared with 200 mL. Furthermore
the nutrition target was achieved somewhat faster using
the higher limit for gastric residual volume. This Spanish
multicentre study gives good evidence that naso-gastric
feeding can be used safely and efficiently in an unselected
group of mechanically ventilated patients. In another
Spanish single-centre study Acosta-Escribano et al. [92]
reported that transpyloric feeding is associated with a
lower incidence of pneumonia and a higher volume of
received nutrition as compared with gastric feeding. The
use of probiotics in enteral feeding is highly controversial,
related to the strain(s) of Lactobacilli used and the patient
selection. Barraud et al. [93] reported on a single-centre
study where 167 patients in a medical ICU on short-term
mechanical ventilation were randomised to probiotics or
placebo. The results were contradictory in different pre-
defined subgroups of septic patients, and the authors
conclude that prophylactic treatment with probiotics
cannot be encouraged presently.
Parenteral nutrition
Parenteral nutrition (PN), either alone or in combination
with enteral nutrition, can improve nutrient delivery to
critically ill patients. Lipids provide a key source of cal-
ories within PN formulations, preventing or correcting
energy deficits and improving outcomes. Calder et al. [94]
reviewed the role of parenteral lipid emulsions (LEs) in
the management of critically ill patients. Soybean-oil-
based LEs with high contents of polyunsaturated fatty
acids (PUFA) may be associated with increased rates of
infection and lipid peroxidation, which can exacerbate
oxidative stress. More recently developed parenteral LEs
employ partial substitution of soybean oil with oils
providing medium-chain triglycerides, omega-9 mono-
unsaturated fatty acids or omega-3 PUFA. Many of these
LEs have demonstrated reduced effects on oxidative
stress, immune responses and inflammation. However, the
effects of these LEs on clinical outcomes have not been
extensively evaluated. The authors concluded that current
data are limited and sometimes inconsistent because of
the heterogeneity of the study designs and patient popu-
lations. Consequently, the prescription of PN containing
LEs should be based on available clinical data, while
considering the individual patient’s physiologic profile
and therapeutic requirements.
Metabolism
The use of predictive markers give information that may
add to the conventional scoring systems. Piton et al. [95]
reported that the plasma citrullin concentration may add
predictive value to SOFA scoring in ICU patients without
renal or intestinal failure. It is not clear if this finding is
independent from the well-known fact that a low plasma
glutamine concentration is an independent predictor
of ICU outcome. Lindner et al. [96] reported from a
retrospective analysis of 2,700 patients undergoing car-
diothoracic surgery that ICU-acquired hypernatraemia is
an independent risk factor for ICU mortality. If this
finding is confined to this specific patient group or can be
generalised to other groups of ICU patients remains to be
elucidated. Iron deficiency in ICU patients may be diffi-
cult to diagnose as the general inflammation seen in most
ICU patients induces anaemia by itself. By the analysis of
serum hepcidin Lasocki et al. [97] showed that anaemia
related to iron deficiency in ICU patients can be separated
and hepcidin therefore may be a useful marker.
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The inflammatory response seen in conjunction with
sepsis may be regarded as an asset or a threat for the indi-
vidual patient. Andreasen et al. [98] studied patients with
type II diabetes and reported that the cytokine response to
an endotoxin challenge is attenuated when compared with
that seen in healthy controls. This may explain the higher
susceptibility to sepsis in this patient group. Pittet et al. [99]
reported that an attenuated inflammatory response occurred
in healthy volunteers pretreated with fish oil rich in n-3
polyunsaturated fatty acids. This particular study was a
dose-finding exercise showing a more pronounced blunting
when a moderate dose of fish oil was given immediately
before the endotoxin challenge.
Ethics
Intensive Care Medicine published several articles on
ethics during 2010.
Predictions of the need for critical care within the
H1N1 influenza pandemic suggested overwhelming need
beyond potential resources, necessitating rationing of care
via triaging. In the June issue, Eastman et al. [100]
described a triage model derived from informed discourse
within a conjoined UK National Health System (NHS)
and University Clinical Ethics Committee, supplemented
by specialists in intensive care and infectious diseases.
The model, which partially suspends usual clinical judg-
ment applied to individuals in favour of also utilizing
organ failure scores, includes minimization of aggregate
influenza morbidity and mortality, and minimization of
psychological stress upon staff making triaging decisions.
A mismatch appears between a clinically and ethically
acceptable model of triaging, based upon a public health
approach, and the law, based upon the paradigm of the
individual patient. Fortunately, the H1N1 pandemic was
less severe than predicted, allowing time for calm con-
sideration, debate and decision making about what model
of triaging should be adopted whenever it might be nec-
essary in the future.
Another paper addressed a similar issue [101], with the
attempt of providing a revised definition, process and pur-
pose of triage to maximise the number of patients receiving
intensive care during a crisis. The authors redefined the
decision-making processes regarding treatment decisions
during a pandemic, recommending new methods of inten-
sive care provision and the use of a ‘ranking’ system for
patients excluded from intensive care, defining the role of
non-intensive care specialists, and applying two types of
triage as ‘organisational triage’ and ‘treatment triage’ based
on the demand for intensive care. This different approach
could maximise the number of patients receiving intensive
care based on individual patients’ best interests.
Le Conte et al. [102] in a 4-month prospective survey
described the characteristics of patients who died in 174
French and Belgian emergency departments and the
decisions to withhold or withdraw life support. Of 2,512
patients enrolled, life-support therapy was initiated in
1,781 patients (73.6%). Palliative care was undertaken for
1,373 patients (56.7%). A decision to withhold or with-
draw life-sustaining treatments was taken for 1,907
patients (78.8%) and mostly concerned patients over
80 years old, with underlying metastatic cancer or pre-
vious functional limitation. Decisions were discussed with
family or relatives in 58.4% of cases. The decision was
made by a single ED physician in 379 cases (19.9%), and
by at least two ED physicians in 1,528 cases (80.1%). The
authors concluded that training of future ED physicians
must be aimed at improving the level of care of dying
patients, with particular emphasis on collegial decision-
taking and institution of palliative care.
Research in the emergency and intensive care medi-
cine poses difficult problems about consent.
Deferred consent has been proposed as a strategy to
allow the enrolment of patients in these specific contexts,
but the inability to obtain deferred consent due to early
death in emergency research may affect validity of clinical
trial results. Jansen et al. [103] analysed the unadjusted
and adjusted primary outcome measures in the field of
intensive care medicine including (n = 348) or excluding
(n = 289) patients with missing deferred consent from a
randomized controlled trial. Thirty-nine patients (11%)
died early, before the patient or his/her proxy could be
approached and consent be obtained. In another 20
patients (6%), it was not possible to inform proxies and ask
consent within the period of study procedures. A signifi-
cant treatment effect (p = 0.006) in the adjusted analysis
became non-significant (p = 0.35) when the patients with
missing deferred consent were excluded. It was concluded
that the exclusion of patients without obtained deferred
consent can reduce statistical power, introduce selection
bias, make randomization asymmetrical, decrease external
validity and thereby jeopardize study results.
At present no consensus exists on uniform criteria for
defining a potential organ donor. Although the term is
increasingly being used in recent literature, it is seldom
defined in detail. De Groot et al. [104] explored the difficult
issue of potential organ donors on imminent brain death.
The authors organized meetings with representatives from
the fields of clinical neurology, neurotraumatology,
intensive care medicine, transplantation medicine, clinical
intensive care ethics and organ procurement management.
During these meetings, all possible criteria were discussed
to identify a patient with a reasonable probability of
becoming brain dead focusing the practical usefulness of
two validated coma scales (Glasgow Coma Scale and the
FOUR Score), brain stem reflexes and respiration to define
imminent brain death. Furthermore the criteria to deter-
mine irreversibility and futility in acute neurological
conditions were discussed. Through this multidisciplinary
dicussion a patient fulfilling the criteria of imminent brain
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death was defined as a mechanically ventilated deeply
comatose patient, admitted to an ICU, with irreversible
catastrophic brain damage of known origin. The condition
of imminent brain death should require either a Glasgow
Coma Score of 3 and the progressive absence of at least
three out of six brain stem reflexes or a FOUR Score of
E(0)M(0)B(0)R(0).
A 12-month, prospective, multicentre observational
study was conducted in 84 Italian ICUs to appraise the
end-of-life decision-making and to evaluate the associa-
tion between the average inclination to limit treatment
and overall survival [105]. Data collection included des-
cription, treatment limitation and decision-makers,
involvement of patients and relatives, and organ donation
of 3,793 consecutive patients who died in ICU or were
discharged in terminal condition during 2005. Treatment
limitation preceded 62% of deaths. In 25% of cases,
nurses were involved in the decision. Half the limitations
were do-not-resuscitate orders, with the remaining half
almost equally split between withholding and withdraw-
ing treatment. Units less inclined to limit treatments (OR
\0.77) showed higher overall standardized mortality ratio
(1.08; 95% CI 1.04–1.12). The authors concluded that
treatment limitation is common in Italian ICUs and still
principally under physicians’ responsibility. Units with
below-average inclination to limit treatments have worse
performance in terms of overall mortality. This result was
important as it showed that limitation is not against the
patient’s interests, but vice versa the inclination to limit
treatments at the end of life can be taken as an indication
of quality in the unit.
Miscellanea
It is especially appreciated when investigators have the
courage to present research on very rare, but sometimes
important topics in intensive care medicine. One example
is a review by Struck et al. [106] on the current literature
on severe cutaneous adverse reactions that are not asso-
ciated with burn injuries. They present life-threatening
examples such as Stevens–Johnson syndrome and toxic
epidermal necrolysis, and conclude that these patients will
substantially benefit from early interdisciplinary care and
thorough consideration of complications during transport
and intensive care treatment. The attending medical team
should be aware of possible underlying diseases and
instigating substances and these patients should be treated
in a manner similar to severe burn patients. Although
touching a quite different field of intensive care medicine,
the review on the use of hypothermia in acute liver failure
is also very interesting and possibly a bit nearer to the daily
practice of the intensivist [107]. The investigators evalu-
ated the present data on the safety and efficacy of induced
moderate hypothermia combined with intracranial pres-
sure (ICP) monitoring in critically ill patients with acute
liver failure. They selected five case series in the literature
with significant heterogeneity, as expected. Nonetheless,
they demonstrated that this approach consistently
improved ICP, cerebral perfusion pressure (CPP) and
cerebral blood flow (CBF), concluding that well-designed
prospective clinical trials are warranted. Finally, the use of
direct thrombin inhibitors in intensive care medicine was
the topic of another literature review [108]. The specific
question was whether this group of alternative anticoag-
ulants provides safety and efficacy when used in the field
of intensive care medicine. For this purpose, the investi-
gators present a synopsis of scientific evidence, expert
opinion, open forum commentary and clinical feasibility
data. They conclude that these drugs could offer potential
advantages over heparins due to their direct antithrombotic
potential without direct activation of platelets. Nonethe-
less, cautious dosing and close drug monitoring are
required, with special regard to existing multiple organ
dysfunctions and numerous comedications.
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